Last filing: Jun 23, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Director | Aug 7, 2024 | Jun 23, 2026 |
| Kailera Therapeutics, Inc. (KLRA) | Director | Apr 16, 2026 | Apr 20, 2026 |
| Cencora (COR) | Director | Nov 5, 2024 | Mar 9, 2026 |
| International Flavors & Fragrances (IFF) | Former Chief Executive Officer | Mar 3, 2022 | Mar 5, 2024 |
| Merck & Co. (MRK) | Former EVP & Pres ? Human Health | Jan 10, 2019 | Nov 4, 2021 |
| DuPont (DD) | Former Director | Jun 5, 2019 | Apr 30, 2021 |
Also a director at
Kailera Therapeutics, Inc. (KLRA), Cencora (COR), DuPont (DD) (no filing in the last 18 months)
Recent filings
The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.